Skip to main content
Clinical Trials/NCT00889655
NCT00889655UnknownPhase 4

A Prospective, Randomized Controlled Trial Comparing the Efficacy and Patient Tolerability of MiraLAX (PEG 3350) vs Golytely as Bowel Preparation for Screening Colonoscopy

Oregon Health and Science University1 site in 1 country432 target enrollmentStarted: May 2009Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Enrollment
432
Locations
1
Primary Endpoint
bowel cleanliness as rated by the boston bowel prep survey

Study Overview

Brief Summary

Prior to colonoscopies, the colon is cleansed using a laxative. Golytely is approved by the FDA for this purpose. Another laxative, called MiraLax, is approved by the FDA to relieve constipation, but it is not approved specifically for preparation for a colonoscopy. Nonetheless, it is commonly used in clinical practice for this purpose, just as is Golytely. The purpose of this study is to compare Golytely and MiraLax in two ways: to see whether one is better tolerated by patients than the other and to see whether one more effectively cleanses the bowel than the other. The investigators' hypothesis is that these 2 bowel preparation methods are equally effective in bowel cleansing, but that patients prefer Miralax to Golytely.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Investigator)

Eligibility Criteria

Ages
50 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • average risk screening for colon cancer

Exclusion Criteria

  • subjects with a history of constipation

Arms & Interventions

Golytely

Active Comparator

216 patients at random will provided a prescription for the standard 4 L golytely preparation as the bowel cleanser for their colonoscopy

Intervention: Golytely (polyethylene glycol) (Drug)

MiraLax

Experimental

216 patients will be randomized to take 238 gm of miralax mixed with 64 oz of gatorade for their bowel cleanser

Intervention: MiraLax (polyethylene glycol 3350) (Drug)

Outcomes

Primary Outcomes

bowel cleanliness as rated by the boston bowel prep survey

Time Frame: measured at the time of colonoscopy

Secondary Outcomes

  • patient tolerability(measured at check in to colonoscopy)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

A Trial Comparing Bowel Preparation and... | Clinical Trial